Late Toxicity, Cohort Continuity, and Endpoint Transparency in Triplet Chemoradiotherapy for Anal Cancer.

Russi EG.

Open source

DOI
10.1016/j.clcc.2026.08.001
Published
2026-08-11
Container
Clin Colorectal Cancer
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.clcc.2026.08.001,
  title = {Late Toxicity, Cohort Continuity, and Endpoint Transparency in Triplet Chemoradiotherapy for Anal Cancer.},
  author = {Russi EG.},
  year = {2026},
  journal = {Clin Colorectal Cancer},
  doi = {10.1016/j.clcc.2026.08.001},
  url = {https://doi.org/10.1016/j.clcc.2026.08.001}
}

RIS

TY  - JOUR
TI  - Late Toxicity, Cohort Continuity, and Endpoint Transparency in Triplet Chemoradiotherapy for Anal Cancer.
AU  - Russi EG.
PY  - 2026
JO  - Clin Colorectal Cancer
DO  - 10.1016/j.clcc.2026.08.001
UR  - https://doi.org/10.1016/j.clcc.2026.08.001
ER  - 

APA

EG., R. (2026). Late Toxicity, Cohort Continuity, and Endpoint Transparency in Triplet Chemoradiotherapy for Anal Cancer.. Clin Colorectal Cancer. https://doi.org/10.1016/j.clcc.2026.08.001

Source records